SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-007271
Filing Date
2017-06-28
Accepted
2017-06-28 16:42:28
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1150087
2 ex23-1.htm EX-23.1 4690
3 ex31-1.htm EX-31.1 18808
4 ex32-1.htm EX-32.1 7245
  Complete submission text file 0001493152-17-007271.txt   3481729

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vbio-20170331.xml EX-101.INS 395146
6 XBRL SCHEMA FILE vbio-20170331.xsd EX-101.SCH 34977
7 XBRL CALCULATION FILE vbio-20170331_cal.xml EX-101.CAL 40208
8 XBRL DEFINITION FILE vbio-20170331_def.xml EX-101.DEF 141609
9 XBRL LABEL FILE vbio-20170331_lab.xml EX-101.LAB 264118
10 XBRL PRESENTATION FILE vbio-20170331_pre.xml EX-101.PRE 220881
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-53832 | Film No.: 17935737
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9